Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEG vs Conventional Coagulation Parameters in Non-Variceal Bleed
NCT02689232Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Feb 2016
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Randomised, open-label trial of fresh-frozen plasma and cryoprecipitate in coagulopathy and Gastrointestinal Bleeding (GIB), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Amount of Fresh Frozen Plasma transfusion at 42 days. Started Feb 2016; status: completed.
02
Drugs
fresh-frozen plasmacryoprecipitate
03
Conditions
coagulopathyGastrointestinal Bleeding (GIB)
Beyond the preview
Go deeper on NCT02689232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689232.